E-cigarettes and Novel Tobacco Products: Use and Cessation, co-hosted by ATTUD

Dr. Pamela Ling is Professor of Medicine and Director of the Center for Tobacco Control Research and Education at the University of California San Francisco.  Her research focuses on tobacco, media, social marketing, and young adults.  The work includes analyses of thousands of previously secret tobacco industry documents detailing industry marketing strategies. Dr. Ling has special interest in the marketing of novel tobacco products including e-cigarettes, the global proliferation of U.S. tobacco marketing strategies, and using market research strategies to inform innovative clinical and public health interventions.  She has contributed to three Surgeon General’s Reports on Tobacco and has been member of the American Society for Clinical Investigation since 2016.  Dr. Ling has an active clinical practice in General Internal Medicine.

Dr. Michael Steinberg is Professor and Chief in the Division of General Internal Medicine and Medical Director of the Rutgers Center for Tobacco Studies. His ongoing efforts include NCI-funded research on tobacco use behaviors, treatment, and physician communication regarding e-cigarettes. He also coordinates the 11 New Jersey tobacco Quitcenters, is project lead for the NCI C3I tobacco initiative at the Cancer Institute of New Jersey, and directs the Screen NJ Lung Cancer Screening program.